123
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Emergence of Candida auris is Not Associated with Changes in Antifungal Prescription at Hospitals

ORCID Icon, ORCID Icon, , , , ORCID Icon, , , & ORCID Icon show all
Pages 1419-1429 | Received 07 Dec 2023, Accepted 23 Mar 2024, Published online: 11 Apr 2024

References

  • Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi. 2017;3:57. doi:10.3390/jof3040057
  • Wong SC, Chan VWM, Lam GK, et al. The use of multi-pronged screening strategy to understand the epidemiology of carbapenemase-producing Enterobacteriaceae in Hong Kong: transition from epidemic to endemic setting. Eur J Clin Microbiol Infect Dis. 2021;40:2017–2022. doi:10.1007/s10096-021-04173-x
  • Wong SC, Lam GK, Chen JH, et al. Air dispersal of multidrug-resistant Acinetobacter baumannii: implications for nosocomial transmission during the COVID-19 pandemic. J Hosp Infect. 2021;116:78–86. doi:10.1016/j.jhin.2021.08.005
  • Wong SC, Chen JH, So SY, Ho PL, Yuen KY, Cheng VC. Gastrointestinal colonization of meticillin-resistant Staphylococcus aureus: an unrecognized burden upon hospital infection control. J Hosp Infect. 2022;121:65–74. doi:10.1016/j.jhin.2021.12.016
  • Wong SC, Chan VW, AuYeung CH, et al. Air dispersal of respiratory viruses other than severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and the implication on hospital infection control. Infect Control Hosp Epidemiol. 2023;44:768–773. doi:10.1017/ice.2022.186
  • Wong SC, Chan VW, Yuen LL, et al. Air dispersal of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): implications for hospital infection control during the fifth wave of coronavirus disease 2019 (COVID-19) due to the SARS-CoV-2 omicron variant in Hong Kong. Infect Control Hosp Epidemiol. 2023;44:1321–1324. doi:10.1017/ice.2022.258
  • Cheng VC, Wong LM, Tai JW, et al. Prevention of nosocomial transmission of norovirus by strategic infection control measures. Infect Control Hosp Epidemiol. 2011;32:229–237. doi:10.1086/658330
  • Cheng VCC, Wong SC, Chiu KHY, Yip CCY, Wong SCY, Yuen KY. Detection of norovirus in air samples in a non-vomiting patient: implications of testing saliva for norovirus in an immunocompromised host. J Hosp Infect. 2019;103:357–358. doi:10.1016/j.jhin.2019.07.011
  • Gold JAW, Adjei S, Gundlapalli AV, et al. Increased hospitalizations involving fungal infections during COVID-19 pandemic, United States, January 2020-December 2021. Emerg Infect Dis. 2023;29:1433–1437. doi:10.3201/eid2907.221771
  • Escribano P, Guinea J. Fluconazole-resistant Candida parapsilosis: a new emerging threat in the fungi arena. Front Fungal Biol. 2022;3:1010782. doi:10.3389/ffunb.2022.1010782
  • Koulenti D, Karvouniaris M, Paramythiotou E, et al. Severe Candida infections in critically ill patients with COVID-19. J Intensive Med. 2023;3:291–297. doi:10.1016/j.jointm.2023.07.005
  • Hanson BM, Dinh AQ, Tran TT, et al. Candida auris Invasive Infections during a COVID-19 Case Surge. Antimicrob Agents Chemother. 2021;65:e0114621. doi:10.1128/AAC.01146-21
  • Khojasteh S, Jafarzdeh J, Hosseini SA, et al. Candida auris and COVID-19: a health threatening combination. Curr Med Mycol. 2022;8:44–50. doi:10.18502/cmm.8.3.11211
  • Armstrong PA, Rivera SM, Escandon P, et al. Hospital-associated multicenter outbreak of emerging fungus candida auris, Colombia, 2016. Emerg Infect Dis. 2019;25:1339–1346. doi:10.3201/eid2507.180491
  • Biran R, Cohen R, Finn T, et al. Nationwide outbreak of candida auris infections driven by COVID-19 hospitalizations, Israel, 2021-2022. Emerg Infect Dis. 2023;29:1297–1301. doi:10.3201/eid2907.221888
  • Hospital authority annual report 2015-2016. Available from: https://www.ha.org.hk/visitor/ha_visitor_index.asp?Content_ID=235572&Lang=ENG. Accessed October 15, 2023.
  • Hospital authority major statistics. Available from: https://www3.ha.org.hk/Data/HAStatistics/MajorReport. Accessed October 15, 2023.
  • Cheng VC, Wong SC, So SY, et al. Decreased antibiotic consumption coincided with reduction in bacteremia caused by bacterial species with respiratory transmission potential during the COVID-19 pandemic. Antibiotics. 2022;11:746. doi:10.3390/antibiotics11060746
  • Wong SC, Chau PH, So SY, et al. Control of healthcare-associated carbapenem-resistant Acinetobacter baumannii by enhancement of infection control measures. Antibiotics. 2022;11:1076. doi:10.3390/antibiotics11081076
  • Wong SC, Chen JH, Chau PH, et al. Gastrointestinal colonization of carbapenem-resistant Acinetobacter baumannii: what is the implication for infection control? Antibiotics. 2022;11:1297. doi:10.3390/antibiotics11101297
  • Wong SC, Chau PH, So SY, et al. Epidemiology of multidrug-resistant organisms before and during COVID-19 in Hong Kong. Infect Prev Pract. 2023;5:100286. doi:10.1016/j.infpip.2023.100286
  • Fan M, Wong SC, Yu Q, et al. Epidemiology and risk factors for carbapenemase-producing Enterobacteriaceae carriage in the hospital: a population-based nested case-control study. J Glob Antimicrob Resist. 2023;33:242–248. doi:10.1016/j.jgar.2023.03.013
  • Centre for Health Protection. Alert on the rise in Candida auris colonisation in Hong Kong; 2020. Available from: https://www.chp.gov.hk/files/pdf/lti_c_auris_20201015_eng.pdf. Accessed November 16, 2023.
  • Cheng VC, Tai JW, Wong LM, et al. Effect of proactive infection control measures on benchmarked rate of hospital outbreaks: an analysis of public hospitals in Hong Kong over 5 years. Am J Infect Control. 2015;43:965–970. doi:10.1016/j.ajic.2015.04.203
  • Teo JQ, Candra SR, Lee SJ, et al. Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes. Antimicrob Resist Infect Control. 2017;6:27. doi:10.1186/s13756-017-0184-1
  • Tan BH, Chakrabarti A, Li RY; Asia Fungal Working Group (AFWG), et al. Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect. 21;2015:946–953. doi:10.1016/j.cmi.2015.06.010
  • Ricotta EE, Lai YL, Babiker A, et al. Invasive candidiasis species distribution and trends, United States, 2009-2017. J Infect Dis. 2021;223:1295–1302. doi:10.1093/infdis/jiaa502
  • Rhodes J, Fisher MC. Global epidemiology of emerging Candida auris. Curr Opin Microbiol. 2019;52:84–89. doi:10.1016/j.mib.2019.05.008
  • Schelenz S, Hagen F, Rhodes JL, et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control. 2016;5:35. doi:10.1186/s13756-016-0132-5
  • Prestel C, Anderson E, Forsberg K, et al. Candida auris Outbreak in a COVID-19 specialty care unit - Florida, July-august 2020. MMWR Morb Mortal Wkly Rep. 2021;70:56–57. doi:10.15585/mmwr.mm7002e3
  • Spivak ES, Hanson KE. Candida auris: an emerging fungal pathogen. J Clin Microbiol. 2018;56:e01588–17. doi:10.1128/JCM.01588-17
  • Chakrabarti A, Sood P. On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points. J Med Microbiol. 2021;70:001318. doi:10.1099/jmm.0.001318
  • Sarma S, Upadhyay S. Current perspective on emergence, diagnosis and drug resistance in Candida auris. Infect Drug Resist. 2017;10:155–165. doi:10.2147/IDR.S116229
  • Pathadka S, Yan VKC, Neoh CF, et al. Global consumption trend of antifungal agents in humans from 2008 to 2018: data from 65 middle- and high-income countries. Drugs. 2022;82:1193–1205. doi:10.1007/s40265-022-01751-x
  • Sabino R, Veríssimo C, Pereira ÁA, Antunes F. Candida auris, an agent of hospital-associated outbreaks: which challenging issues do we need to have in mind? Microorganisms. 2020;8:181. doi:10.3390/microorganisms8020181
  • Ahmad S, Asadzadeh M. Strategies to prevent transmission of candida auris in healthcare settings. Curr Fungal Infect Rep. 2023;17:36–48. doi:10.1007/s12281-023-00451-7
  • Cheng VC, Chan JF, Wong SC, et al. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area. Chin Med J. 2013;126:4504–4509. doi:10.3760/cma.j.issn.0366-6999.20130741
  • Cheng VC, Tai JW, Chen JH, et al. Proactive infection control measures to prevent nosocomial transmission of vancomycin-resistant enterococci in Hong Kong. J Formos Med Assoc. 2014;113:734–741. doi:10.1016/j.jfma.2014.04.001
  • Cheng VCC, Wong SC, KKW T, Ho PL, Yuen KY. Preparedness and proactive infection control measures against the emerging novel coronavirus in China. J Hosp Infect. 2020;104:254–255. doi:10.1016/j.jhin.2020.01.010
  • Cheng VC, Chen JH, Poon RW, et al. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene. Eur J Clin Microbiol Infect Dis. 2015;34:713–718. doi:10.1007/s10096-014-2281-x
  • Cheng VC, Tai JW, Li WS, et al. Implementation of directly observed patient hand hygiene for hospitalized patients by hand hygiene ambassadors in Hong Kong. Am J Infect Control. 2016;44:621–624. doi:10.1016/j.ajic.2015.11.024
  • Cheng VC, Tai JW, Chau PH, et al. Successful control of emerging vancomycin-resistant enterococci by territory-wide implementation of directly observed hand hygiene in patients in Hong Kong. Am J Infect Control. 2016;44:1168–1171. doi:10.1016/j.ajic.2016.03.050
  • Cheng VCC, Wong SC, Wong SCY, Yuen KY. Directly observed hand hygiene - from healthcare workers to patients. J Hosp Infect. 2019;101:380–382. doi:10.1016/j.jhin.2018.11.016
  • Cheng VCC, Wong SC, Chen JHK, et al. Escalating infection control response to the rapidly evolving epidemiology of the coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect Control Hosp Epidemiol. 2020;41:493–498. doi:10.1017/ice.2020.58
  • Cheng VC, Wong SC, Chan VW, et al. Air and environmental sampling for SARS-CoV-2 around hospitalized patients with coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2020;41:1258–1265. doi:10.1017/ice.2020.282
  • Tang JW, Marr LC, Tellier R, Dancer SJ. Airborne transmission of respiratory viruses including severe acute respiratory syndrome coronavirus 2. Curr Opin Pulm Med. 2023;29:191–196. doi:10.1097/MCP.0000000000000947
  • Wong SC, Yuen LL, Chan VW, et al. Airborne transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): what is the implication of hospital infection control? Infect Control Hosp Epidemiol. 2022;43:1522–1523. doi:10.1017/ice.2021.318
  • Wong SC, Chen JH, Yuen LL, et al. Air dispersal of meticillin-resistant Staphylococcus aureus in residential care homes for the elderly: implications for transmission during the COVID-19 pandemic. J Hosp Infect. 2022;123:52–60. doi:10.1016/j.jhin.2022.02.012
  • Taori SK, Rhodes J, Khonyongwa K, et al. First experience of implementing Candida auris real-time PCR for surveillance in the UK: detection of multiple introductions with two international clades and improved patient outcomes. J Hosp Infect. 2022;127:111–120. doi:10.1016/j.jhin.2022.06.009
  • Wong SC, Yuen LL, Li CK, Kwok MO, Chen JH, Cheng VC. Proactive infection control measures to prevent nosocomial transmission of Candida auris in Hong Kong. J Hosp Infect. 2023;134:166–168. doi:10.1016/j.jhin.2022.12.020
  • Didik T, Yau AP, Cheung HL, et al. Long-range air dispersion of Candida auris in a cardiothoracic unit outbreak in Hong Kong. J Hosp Infect. 2023;142:105–114. doi:10.1016/j.jhin.2023.09.019
  • Yadav A, Jain K, Wang Y, et al. Candida auris on apples: diversity and clinical significance. mBio. 2022;13:e0051822. doi:10.1128/mbio.00518-22
  • Arora P, Singh P, Wang Y, et al. Environmental isolation of candida auris from the coastal Wetlands of Andaman Islands, India. mBio. 2021;12:e03181–20. doi:10.1128/mBio.03181-20
  • Zhang Z, Zhu R, Luan Z, Ma X. Risk of invasive candidiasis with prolonged duration of ICU stay: a systematic review and meta-analysis. BMJ Open. 2020; 10:e036452.
  • Thomas-Rüddel DO, Schlattmann P, Pletz M, Kurzai O, Bloos F. Risk factors for invasive candida infection in critically Ill patients: a systematic review and meta-analysis. Chest. 2022;161:345–355. doi:10.1016/j.chest.2021.08.081